← Back to Search

Artificial Intelligence

optima4BP for High Blood Pressure

N/A
Waitlist Available
Led By Liviu Klein, MD
Research Sponsored by Optima Integrated Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months and 12 months
Awards & highlights

Study Summary

This trial is testing a new way to optimize blood pressure treatment for patients with essential hypertension.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction in systolic BP [SBP] (mmHg) measured remotely [Time frame: 0 - 6 months]
Secondary outcome measures
Incidence of Adverse Events [Time Frame: full 12 months]
Sustained remote SBP Target during observational period [Time Frame: 6 - 12 months (end of study)]

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: optima4BPExperimental Treatment1 Intervention
Treating physicians receive periodic (every 5-8 weeks) medication treatment recommendations intended to optimize the current patient treatment. The recommendations are generated based on periodic remote data collected from the patient and from the Electronic Health Record. The analysis of the data allows assessment of the patient's response to current treatment and need for a treatment optimization. If a treatment optimization is needed, one is generated and sent to the treating physician for consideration.
Group II: Standard of Care (SOC)Active Control1 Intervention
The treating physician follows usual care practices.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoOTHER
2,507 Previous Clinical Trials
15,238,403 Total Patients Enrolled
Optima Integrated HealthLead Sponsor
2 Previous Clinical Trials
28 Total Patients Enrolled
Gabriela Voskerician, PhDStudy DirectorOptima Integrated Health
1 Previous Clinical Trials
28 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Tailored Drug Titration Using Artificial Intelligence
2020. "Tailored Drug Titration Using Artificial Intelligence". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04223934.
~32 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top